Trismus Clinical Trial
Official title:
Prophylactic Physiotherapy Development Of Radiation-Induced Trismus In Patients With Head And Neck Cancer: Randomized Controlled Clinical Trial
The purpose of this study is to assess the effect of two protocols of physiotherapeutic exercises in the maintenance and/or increase of the mandibular range of movement in patients suffering from head and neck cancer (HNC) who are undergoing radiotherapy.
Because of contradictory data in the literature with regards to the efficiency of
physiotherapeutic techniques to prevent and treat radiation-induced trismus, we believe there
is a need to better investigate the efficiency and the quality of life resulting from the
different prophylactic physiotherapeutic techniques for radiation-induced trismus in patients
with HNC. After the conclusion of this research, we hope to suggest a suitable
physiotherapeutic protocol to prevent this complication thereby allowing for an improvement
in patients' quality of life.
Data collection:
All patients who begin Radiotherapy the Hospital will attend a group meeting with the nursing
staff in order to receive information about their treatment. In the groups, we will identify
patients who meet the study inclusion criteria and explain the Informed Consent Form. After
we explain to patients their rights in accordance with resolution 196/96 of the National
Health Council and they agree to take part by signing the consent form, we will begin
gathering data.
The gathering of data will be done always by the same researcher, who will assess the patient
twice; the first assessment will take place before the onset of radiotherapy treatment,
preferably on the day that the patient undergoes simulation (baseline), the second assessment
will take place immediately after the last session of radiotherapy (post radiotherapy), third
assessment will take a place six months after radiotherapy and the late follow-up one year
after the radiotherapy treatment. Each patient will have a different total duration of
radiotherapy regarding the dosage of radiation and type of tumor. It is expected that the
total duration of radiation will vary between 45 to 60 days.
Prior to that, all patients will be interviewed on a one-to-one basis in the premises of the
Radiotherapy Service to provide their medical history. Other information such as tumor site,
neoplastic histological type, staging,radiation field, dosage for each radiotherapy session,
bilateral or unilateral presentation and aim of treatment (palliative or curative) will be
taken from the patient's hospital records.
The physical examination will take place in accordance with the guidelines and specifications
of the Research Diagnostic Criteria for Temporomandibular Disorders - RDC/TMD, which
evaluates variables such as the range of motion of the temporomandibular joint (TMJ), joint
sounds and level of pain when pressed by the fingers and to the mastication muscles. RDC/TMD
is widely used in the scientific and clinical practice for assessment of temporomandibular
dysfunction, as it has been officially translated into 18 languages, including Portuguese.
After recording the patient´s medical history and carrying out a physical examination, the
patient will receive the University of Washington Quality of Life Questionnaire, version 4.
After undergoing assessment, patients will be given instructions about the physiotherapy
exercises to be performed with the aid of an assistant physiotherapist. Patients will be
randomly placed into 3 Groups.
The control group will not receive any of the protocols tested in the study, but together
with the other groups, will receive the regular treatment offered by the institution, which
is made up of guidance and advice given by the hospital´s nursing team about the radiotherapy
treatment.
In order to assess patients' compliance with the protocol, they will be given a training
calendar at baseline in order to record their compliance or not with the regime. Completed
calendars will be collected at post radiotherapy.
Sample Size:
The sample size has been determined with the aid of the software PEPI (Programs for
Epidemiologists) version 4.0 and based in the works of Tang et al.
(2011) and Buchbinder et al. (1993). In order to achieve a significance of 5%, a power of 90%
and an effect size of one standard deviation amongst the groups, we have obtained a total of
at least 23 patients in each of the 3 groups, with a grand total of 69 patients.
Randomization:
The randomization will be done by the software PEPI (Programs for Epidemiologists),
subcategory RANDOM, which will draw the random numbers in each group. The allocation will be
kept secret by the existence of a randomization list which will be kept in an isolated venue.
The sequence of numbers to be used in the randomization will be kept confidential and will
only be disclosed at the exact moment when intervention begins.
Statistical Analysis:
The quantitative variables will be described by standard deviation and mean while the
qualitative variables will be described by absolute and relative frequency.
The Kolmogorov-Smirnov Test will be used to verify data normality. In order to compare intra
and inter groups, the two-way Variable Analysis (ANOVA) for repeated measures with Bonferroni
post-hoc test will be applied. In order to compare the means amongst the groups at the
baseline, the one-way Analysis of Variance (ANOVA) with Tukey´s post-hoc will be used. If
asymmetry is detected, we will apply the Kruskal-Wallis test supplemented by Mann-Whitney
test.
In order to compare distribution, the Pearson chi-square test supplemented by the adjusted
residuals will be applied. In order to compare the domains of Quality of Life, the Analysis
of Variance (ANOVA) with Bonferroni post-hoc will be used for repeated measurements.
In order to assess the correlation between continuous variables, the Pearson linear
correlation test will be used. If asymmetry is detected, the Spearman correlation will be
applied.
The significance level adopted will be that of 5% (p<0,05) and the analyses will be done
using the software SPSS (Statistical Package for the Social Sciences) version 17.0.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05671861 -
Evaluating a Low-Cost Therapeutic Device in Managing Head and Neck Cancer Patients With Radiation-Related Trismus
|
N/A | |
Recruiting |
NCT03442166 -
Effectiveness of Light-emitting Diode (LED) Photobiomodulation in the Extraction of Retained Lower Third Molars
|
Phase 2 | |
Completed |
NCT03178110 -
Manual Therapy and Use of the Dynasplint for Trismus in Patients With Head and Neck Cancer
|
N/A | |
Recruiting |
NCT03979924 -
Mouth Opening, Prevention, Education, Nutrition (OPEN)
|
N/A | |
Completed |
NCT03672669 -
Comparison of the Effect of A-PRF and L-PRF on Outcomes After Removal of Impacted Mandibular Third Molar
|
N/A | |
Active, not recruiting |
NCT00793052 -
Etodalac, Etoricoxib and Dexamethasone for Prevention of Pain ,Swelling and Trismus Following Third Molar Surgery
|
N/A | |
Active, not recruiting |
NCT03170713 -
Impact of Preemptive Intravenous Ibuprofen on Postoperative Edema and Trismus in the Third Molar Teeth
|
N/A | |
Completed |
NCT04280809 -
Effects of Low-level Laser Therapy After Surgical Removal of Impacted Lower Third Molar
|
N/A | |
Completed |
NCT03480035 -
Ideal Point of Transluminal Light in Tracheal Intubation With a Light Wand
|
||
Recruiting |
NCT02602431 -
Low Laser Light Therapy After Impacted Third Molar Removal
|
N/A | |
Completed |
NCT03492814 -
Comparing Different Suturing Techniques on the Post-operative Morbidity After Removal of Impacted Mandibular Third Molar
|
N/A | |
Not yet recruiting |
NCT06148077 -
Manual Therapy for Oral Health on Head and Neck Cancer Survivors
|
N/A | |
Not yet recruiting |
NCT02493179 -
Efficacy Evaluation of the (Serodase 5 mg Tablet) in the Treatment of Inflammation After Third Molar Surgery
|
Phase 4 | |
Active, not recruiting |
NCT04005521 -
Randomized Study Regarding Preventive Jaw- and Swallowing Intervention for Patients With Head and Neck Cancer
|
N/A | |
Not yet recruiting |
NCT04082793 -
Photobiomodulation and Sonophoresis Improving Jaw Mobility and Quality of Life Among Head and Neck Cancer Survivors
|
N/A | |
Suspended |
NCT00507208 -
Dynasplint Therapy for Trismus in Head and Neck Cancer
|
N/A | |
Completed |
NCT05679453 -
Lornoxicam Versus Etodolac After Third Molar Surgery
|
Phase 4 | |
Completed |
NCT03690167 -
Investigation of the Effects of CGF and A-PRF on Pain, Edema and Trismus After Impacted Lower Third Molar Surgery
|
N/A | |
Recruiting |
NCT06458478 -
Effects of the Application of a Hyper-oxygenated Gel After Oral Surgery
|
N/A | |
Not yet recruiting |
NCT05176158 -
Dexketoprofen Dosage According to Chronotherapy
|
N/A |